{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:04Z","timestamp":1793042764101,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T00:00:00Z","timestamp":1743897600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-96089-1","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T16:43:22Z","timestamp":1743957802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Development and validation of interpretable machine learning models to predict distant metastasis and prognosis of muscle-invasive bladder cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Qian","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,6]]},"reference":[{"issue":"1","key":"96089_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni, S. et al. Bladder cancer incidence and mortality: a global overview and recent trends. Eur. Urol. 71(1), 96\u2013108 (2017).","journal-title":"Eur. Urol."},{"issue":"1","key":"96089_CR2","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrc3817","volume":"15","author":"MA Knowles","year":"2015","unstructured":"Knowles, M. A. & Hurst, C. D. Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity. Nat. Rev. Cancer. 15(1), 25\u201341 (2015).","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"96089_CR3","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes, J. et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur. Urol. 71(3), 462\u2013475 (2017).","journal-title":"Eur. Urol."},{"issue":"22","key":"96089_CR4","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1200\/JCO.22.02762","volume":"41","author":"JP Stein","year":"2023","unstructured":"Stein, J. P. et al. Radical cystectomy in the treatment of invasive bladder cancer: long-term results in 1,054 patients. J. Clin. Oncol. 41(22), 3772\u20133781 (2023).","journal-title":"J. Clin. Oncol."},{"issue":"2","key":"96089_CR5","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3233\/BLC-170149","volume":"4","author":"MD Galsky","year":"2018","unstructured":"Galsky, M. D. et al. Real-world effectiveness of chemotherapy in elderly patients with metastatic bladder cancer in the united States. Bladder Cancer. 4(2), 227\u2013238 (2018).","journal-title":"Bladder Cancer"},{"issue":"6","key":"96089_CR6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.eururo.2018.09.001","volume":"74","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch, M. G. K. et al. Epidemiology of bladder cancer: a systematic review and contemporary update of risk factors in 2018. Eur. Urol. 74(6), 784\u2013795 (2018).","journal-title":"Eur. Urol."},{"issue":"5","key":"96089_CR7","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1111\/bju.12601","volume":"114","author":"AB Smith","year":"2014","unstructured":"Smith, A. B. et al. Muscle-invasive bladder cancer: evaluating treatment and survival in the National Cancer Data Base. BJU Int. 114(5): 719\u2013726. (2014).","journal-title":"BJU Int."},{"issue":"2","key":"96089_CR8","doi-asserted-by":"publisher","first-page":"e6972","DOI":"10.1002\/cam4.6972","volume":"13","author":"NW Kang","year":"2024","unstructured":"Kang, N. W. et al. Comparative survival analysis of bladder preservation therapy versus radical cystectomy in muscle-invasive bladder cancer. Cancer Med. 13(2), e6972 (2024).","journal-title":"Cancer Med."},{"issue":"12","key":"96089_CR9","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1172\/JCI139597","volume":"130","author":"X Chen","year":"2020","unstructured":"Chen, X. et al. Urine DNA methylation assay enables early detection and recurrence monitoring for bladder cancer. J. Clin. Invest. 130(12), 6278\u20136289 (2020).","journal-title":"J. Clin. Invest."},{"issue":"6","key":"96089_CR10","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S1470-2045(23)00170-5","volume":"24","author":"AR Zlotta","year":"2023","unstructured":"Zlotta, A. R. et al. Radical cystectomy versus trimodality therapy for muscle-invasive bladder cancer: a multi-institutional propensity score matched and weighted analysis. Lancet Oncol. 24(6), 669\u2013681 (2023).","journal-title":"Lancet Oncol."},{"issue":"2","key":"96089_CR11","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1007\/s11912-020-0880-5","volume":"22","author":"DM Jiang","year":"2020","unstructured":"Jiang, D. M., Chung, P., Kulkarni, G. S. & Sridhar, S. S. Trimodality therapy for muscle-invasive bladder cancer: recent advances and unanswered questions. Curr. Oncol. Rep. 22(2), 14 (2020).","journal-title":"Curr. Oncol. Rep."},{"issue":"7","key":"96089_CR12","doi-asserted-by":"publisher","first-page":"e048008","DOI":"10.1136\/bmjopen-2020-048008","volume":"11","author":"GS Collins","year":"2021","unstructured":"Collins, G. S. et al. Protocol for development of a reporting guideline (TRIPOD-AI) and risk of bias tool (PROBAST-AI) for diagnostic and prognostic prediction model studies based on artificial intelligence. BMJ Open. 11(7), e048008 (2021).","journal-title":"BMJ Open."},{"key":"96089_CR13","doi-asserted-by":"crossref","unstructured":"Wen, P., Wen, J., Huang, X. & Wang, F. Development and validation of nomograms predicting the 5- and 8-year overall and cancer-specific survival of bladder cancer patients based on SEER program. J. Clin. Med., 12(4). (2023).","DOI":"10.3390\/jcm12041314"},{"issue":"1","key":"96089_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12967-020-02308-w","volume":"18","author":"W Fang","year":"2020","unstructured":"Fang, W., Yang, Z. Y., Chen, T. Y., Shen, X. F. & Zhang, C. Ethnicity and survival in bladder cancer: a population-based study based on the SEER database. J. Transl Med. 18(1), 145 (2020).","journal-title":"J. Transl Med."},{"key":"96089_CR15","doi-asserted-by":"crossref","unstructured":"Karakiewicz, P. I. et al. Precystectomy nomogram for prediction of advanced bladder cancer stage. Eur. Urol. 50(6), 1254-60; discussion 1261-2. (2006).","DOI":"10.1016\/j.eururo.2006.06.010"},{"issue":"11","key":"96089_CR16","doi-asserted-by":"publisher","first-page":"e37492","DOI":"10.1097\/MD.0000000000037492","volume":"103","author":"S Li","year":"2024","unstructured":"Li, S. et al. Establishment and validation of nomograms to predict the overall survival and cancer-specific survival for non-metastatic bladder cancer patients: A large population-based cohort study and external validation. Med. (Baltim). 103(11), e37492 (2024).","journal-title":"Med. (Baltim)."},{"key":"96089_CR17","doi-asserted-by":"crossref","unstructured":"Sylvester, R. J. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur. Urol. 49(3), 466-5; discussion 475-7. (2006).","DOI":"10.1016\/j.eururo.2005.12.031"},{"issue":"19","key":"96089_CR18","doi-asserted-by":"publisher","first-page":"4230","DOI":"10.1002\/sim.9025","volume":"40","author":"RD Riley","year":"2021","unstructured":"Riley, R. D. et al. Minimum sample size for external validation of a clinical prediction model with a binary outcome. Stat. Med. 40(19), 4230\u20134251 (2021).","journal-title":"Stat. Med."},{"key":"96089_CR19","doi-asserted-by":"crossref","unstructured":"Li, S., Wang, J., Zhang, Z., Ren, C. & He, D. Individual risk and prognostic value prediction by interpretable machine learning for distant metastasis in neuroblastoma: A population-based study and an external validation. Int. J. Med. Inform. 105813. (2025).","DOI":"10.1016\/j.ijmedinf.2025.105813"},{"issue":"1","key":"96089_CR20","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1023\/A:1012487302797","volume":"46","author":"I Guyon","year":"2002","unstructured":"Guyon, I., Weston, J., Barnhill, S. & Vapnik, V. Gene selection for cancer classification using support vector machines. Mach. Learn. 46(1), 389\u2013422 (2002).","journal-title":"Mach. Learn."},{"issue":"4","key":"96089_CR21","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/bioinformatics\/btr709","volume":"28","author":"R Kolde","year":"2012","unstructured":"Kolde, R., Laur, S., Adler, P. & Vilo, J. Robust rank aggregation for gene list integration and meta-analysis. Bioinformatics 28(4), 573\u2013580 (2012).","journal-title":"Bioinformatics"},{"key":"96089_CR22","doi-asserted-by":"publisher","first-page":"p1903","DOI":"10.21105\/joss.01903","volume":"4","author":"M Lang","year":"2019","unstructured":"Lang, M. et al. mlr3: A modern object-oriented machine learning framework in R. J. Open. Source Softw. 4, p1903 (2019).","journal-title":"J. Open. Source Softw."},{"key":"96089_CR23","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.2147\/RMHP.S310295","volume":"14","author":"K Wang","year":"2021","unstructured":"Wang, K. et al. Improving risk identification of adverse outcomes in chronic heart failure using SMOTE\u2009+\u2009ENN and machine learning. Risk Manag Healthc. Policy. 14, 2453\u20132463 (2021).","journal-title":"Risk Manag Healthc. Policy"},{"key":"96089_CR24","unstructured":"Biecek, P. Dalex: explainers for complex predictive models in R. J. Mach. Learn. Res. 19. (2018)."},{"issue":"1","key":"96089_CR25","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1186\/s12911-021-01639-y","volume":"21","author":"YT Lo","year":"2021","unstructured":"Lo, Y. T., Liao, J. C., Chen, M. H., Chang, C. M. & Li, C. T. Predictive modeling for 14-day unplanned hospital readmission risk by using machine learning algorithms. BMC Med. Inf. Decis. Mak. 21(1), 288 (2021).","journal-title":"BMC Med. Inf. Decis. Mak."},{"key":"96089_CR26","doi-asserted-by":"crossref","unstructured":"Sonabend, R., Kir\u00e1ly, F. J., Bender, A., Bischl, B. & Lang, M. mlr3proba: An R package for machine learning in survival analysis. Bioinformatics. 37(17), 2789\u20132791. (2021).","DOI":"10.1093\/bioinformatics\/btab039"},{"issue":"2","key":"96089_CR27","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.eururo.2012.05.008","volume":"62","author":"V Soukup","year":"2012","unstructured":"Soukup, V. et al. Follow-up after surgical treatment of bladder cancer: a critical analysis of the literature. Eur. Urol. 62(2), 290\u2013302 (2012).","journal-title":"Eur. Urol."},{"issue":"4","key":"96089_CR28","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s00262-024-03651-3","volume":"73","author":"B Li","year":"2024","unstructured":"Li, B. et al. Integrating molecular subtype and CD8(+) T cells infiltration to predict treatment response and survival in muscle-invasive bladder cancer. Cancer Immunol. Immunother. 73(4), 66 (2024).","journal-title":"Cancer Immunol. Immunother"},{"issue":"1","key":"96089_CR29","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1186\/s12885-024-12489-y","volume":"24","author":"X Zhang","year":"2024","unstructured":"Zhang, X. et al. Basement membrane-related MMP14 predicts poor prognosis and response to immunotherapy in bladder cancer. BMC Cancer. 24(1), 746 (2024).","journal-title":"BMC Cancer"},{"key":"96089_CR30","doi-asserted-by":"crossref","unstructured":"Zheng, Q. et al. Predicting lymph node metastasis status from primary muscle-invasive bladder cancer histology slides using deep learning: a retrospective multicenter study. Cancers. 15(11). (2023).","DOI":"10.3390\/cancers15113000"},{"issue":"1","key":"96089_CR31","first-page":"21","volume":"36","author":"N Posielski","year":"2022","unstructured":"Posielski, N., Koenig, H., Ho, O., Porter, C. & Flores, J. P. Use of neoadjuvant chemotherapy in elderly patients with muscle-invasive bladder cancer: a population-based study, 2006\u20132017. Oncology 36(1), 21\u201333 (2022).","journal-title":"Oncology"},{"issue":"12","key":"96089_CR32","doi-asserted-by":"publisher","first-page":"3284","DOI":"10.21037\/tcr-23-1229","volume":"12","author":"S Shi","year":"2023","unstructured":"Shi, S., Peng, G., Luo, L. & Li, D. Predictive nomograms for risk and prognostic factors in metastatic bladder cancer: a population-based study. Transl Cancer Res. 12(12), 3284\u20133302 (2023).","journal-title":"Transl Cancer Res."},{"key":"96089_CR33","doi-asserted-by":"crossref","unstructured":"Matsukawa, A. et al. Trimodality therapy versus radical cystectomy for muscle-invasive bladder cancer: a systematic review and meta-analysis of matched cohort studies. Eur. Urol. Focus (2024).","DOI":"10.1016\/j.euf.2024.11.003"},{"key":"96089_CR34","doi-asserted-by":"crossref","unstructured":"Qiu, J. et al. Comparing long-term survival outcomes for muscle-invasive bladder cancer patients who underwent with radical cystectomy and bladder-sparing trimodality therapy: a multicentre cohort analysis. J. Oncol. 2022, 7306198. (2022).","DOI":"10.1155\/2022\/7306198"},{"key":"96089_CR35","doi-asserted-by":"crossref","unstructured":"Fong, K. Y. et al. Trimodality therapy versus radical cystectomy for muscle-invasive bladder cancer: A systematic review and meta-analysis. Urol. Oncol. (2025).","DOI":"10.1016\/j.urolonc.2025.01.012"},{"issue":"1","key":"96089_CR36","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s12957-023-03161-z","volume":"21","author":"X Su","year":"2023","unstructured":"Su, X., Dong, C., Liao, W. & Liu, W. Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis. World J. Surg. Oncol. 21(1), 271 (2023).","journal-title":"World J. Surg. Oncol."},{"issue":"6","key":"96089_CR37","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1634\/theoncologist.2015-0440","volume":"21","author":"M Yin","year":"2016","unstructured":"Yin, M. et al. Neoadjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and two-step meta-analysis. Oncologist 21(6), 708\u2013715 (2016).","journal-title":"Oncologist"},{"issue":"12","key":"96089_CR38","doi-asserted-by":"publisher","first-page":"3145","DOI":"10.1007\/s11255-022-03339-6","volume":"54","author":"N van Ginkel","year":"2022","unstructured":"van Ginkel, N. et al. Survival outcomes of patients with muscle-invasive bladder cancer according to pathological response at radical cystectomy with or without neo-adjuvant chemotherapy: a case-control matching study. Int. Urol. Nephrol. 54(12), 3145\u20133152 (2022).","journal-title":"Int. Urol. Nephrol."},{"issue":"3","key":"96089_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ultrasmedbio.2024.11.003","volume":"51","author":"M Yan","year":"2025","unstructured":"Yan, M. et al. Comparative analysis of nomogram and machine learning models for predicting axillary lymph node metastasis in early-stage breast cancer: a study on clinically and ultrasound-negative axillary cases across two centers. Ultrasound Med. Biol. 51(3), 463\u2013474 (2025).","journal-title":"Ultrasound Med. Biol."},{"key":"96089_CR40","doi-asserted-by":"publisher","first-page":"114261","DOI":"10.1016\/j.psychres.2021.114261","volume":"306","author":"C Zhang","year":"2021","unstructured":"Zhang, C. et al. Using catboost algorithm to identify middle-aged and elderly depression, National health and nutrition examination survey 2011\u20132018. Psychiatry Res. 306, 114261 (2021).","journal-title":"Psychiatry Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96089-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96089-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96089-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T16:43:27Z","timestamp":1743957807000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-96089-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,6]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["96089"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-96089-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,6]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of The First Affiliated Hospital of Henan University of Science and Technology (protocol code: 2024-03-K0144, approved on 2024-03-20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11795"}}